Clint Taylor, OD
Optometrist · Carmi, ILNPI 1811931769
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,585 of the $48,225 with a category attached, or 94.5%. ABB Con-cise Optical Group LLC accounts for 95.4% of it on its own, with 16 other manufacturers making up the rest. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $643.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ABB Con-cise Optical Group LLC$46K
- Alcon$872
- Coopervision Inc.$236
- Bausch & Lomb, A Division Of Bausch Health US, LLC$160
- Shire North American Group Inc$143
- NEW World Medical,inc.$139
- plus $662 from 11 others
What the payments were for
- Consulting fees$45,58595%
- Food & beverage$2,4605%
- Gifts$750%
- Entertainment$1050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ABB Con-cise Optical Group LLC | 25 | $46,013 |
| Alcon | 15 | $872 |
| Coopervision Inc. | 4 | $236 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $160 |
| Shire North American Group Inc | 3 | $143 |
| NEW World Medical,inc. | 1 | $139 |
| LKC Technologies, Inc. | 1 | $123 |
| Amgen | 2 | $120 |
| Optos, Inc. | 1 | $105 |
| Oyster Point Pharma, Inc. | 3 | $78 |
| AbbVie(2 entities) | 4 | $66 |
| Bausch & Lomb Americas Inc. | 2 | $56 |
| Biotissue Holdings Inc. | 6 | $32 |
| Lombart Brothers, Inc. | 2 | $26 |
| Novartis | 1 | $25 |
| Glaukos Corporation | 1 | $20 |
| Carl Zeiss Meditec USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Contact Lens$37,790
- DAILIES$511
- PANORAMIC OPHTHALMOSCOPE$210
- OCT OPHTHALMOSCOPE$210
- SPECTACLE LENSES$181
- Kahook Dual Blade$139
- Streamline Surgical System$139
- Ahmed Glaucoma Valve$139
- AIR OPTIX$136
- TOTAL30$108
- Clariti Contact Lens$106
- XIIDRA$105
- NFC-700$105
How this compares
$48,225 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 16 | $33,023 |
| LumiganBimatoprost | 48 | $19,118 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $2,905 |
| Latanoprost | 341 | $2,615 |
| Loteprednol Etabonate | 15 | $1,895 |
| Travoprost | 15 | $1,264 |
| Timolol Maleate | 137 | $961 |
| Prednisolone Acetate | 17 | $524 |
| Brimonidine Tartrate | 58 | $428 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $271 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 18 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $56 | $33,02316 claims |
| AbbVieLumigan | $66 | $19,11848 claims |
| AlconSimbrinza | $872 | $2,90511 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $160 | $1,89515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,257 optometrist providers in Illinois.
Other optometrist in Carmi
- Pamela LoweChicago$447K
- Jeffrey LewisChampaign$394K
- Adeyinka AdewaleGodfrey$391K
- Michael ChaglasianChicago$367K
- Jessilin QuintChicago$366K
- Jullian CerasuoloChicago$329K
- Steven EidenDeerfield$259K
- Peter KehoeGalesburg$167K
- Gulroop HansraDowners Grove$151K
- Treacy AdamoHinsdale$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.